Glucose Tolerance Study

Inclusion criteria

• Adults aged 18 years and above
• Generally healthy
• BMI 18.5-29.9 kg/m2
• Able to provide informed consent
• Agree to not participate in another clinical trial while enrolled in this trial
• Agree not to change current diet and/or exercise frequency or intensity during entire study period
• Females using a prescribed form of birth control (e.g. oral contraceptive)
• Able to attend the clinic on all required days.

Exclusion criteria

• Unstable or serious illness (e.g. Serious mood disorders, neurological disorders such as MS, kidney disease, liver disease, heart conditions, thyroid gland dysfunction)
• Known diabetes (Type I or II), or impaired glucose tolerance
• Fasting glucose ≥5.9 mmol/L or known random glucose ≥11.1 mmol/L
• Use of medications that affect glucose metabolism (e.g., corticosteroids, beta-blockers, diuretics).
• Current malignancy (excluding BCC) or chemotherapy and radiotherapy treatment for malignancy within the previous 2 years
• Active smokers, nicotine use, alcohol or drug (prescription or illegal substances) abuse
• Chronic past and/or current alcohol use (>14 alcoholic drinks week)
• Allergic to any of the ingredients in the active or placebo formula
• Consistently (3 or more days per week) taken OEA within the past 4 weeks
• Known pregnant or lactating woman
• Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion
• Participants who have participated in any other non-RDC related clinical study during the past 1 month
• Recent infection or trauma in the month prior to the study or on the days of the clinic visits